Therapy News and Research

RSS

Tamoxifen study counters hopes that drug might protect the heart

Despite previous studies hinting at tamoxifen's potential benefit for breast cancer survivors' heart health, California researchers have found that the breast cancer drug does not decrease survivors' risk of heart attack.

15 May 2005

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.

15 May 2005

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer, particularly if their cancer is fueled by the hormones estrogen or progesterone, according to a data analysis by researchers at Boston's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard School of Public Health.

15 May 2005

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.

15 May 2005

Drug trio increases survival rate in head and neck cancers

Adding a third drug to a standard chemotherapy combination can dramatically improve the survival of patients with advanced head and neck cancer, according to research at Dana-Farber Cancer Institute in Boston.

15 May 2005

Doctors and patients think differently about clinical trials

A survey of patients and physicians regarding clinical trials shows that doctors don't recognize the importance of side effects as a barrier for their patients in deciding about whether to undergo experimental therapy.

15 May 2005

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

15 May 2005

Herceptin could be used safely for bladder cancer

A targeted drug shown to improve the outcome of certain breast cancer patients may be of use in the treatment of advanced cases of bladder cancer, according to new research led by the University of Michigan Comprehensive Cancer Center.

15 May 2005

Robotic surgery dramatically reduces physical trauma for head & neck cancer patients

For patients with cancer of the mouth and throat, surgery is a frequent course of treatment, often leading to speech and swallowing dysfunction and external scarring.

15 May 2005

First advance in pancreatic cancer treatment in a decade offers new hope

The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.

15 May 2005

Great news for breast cancer patients

In encouraging new study results researchers say that modern treatments have significantly boosted the 15-year survival rate for breast cancer, and even better news is that they have also found that drug and hormonal therapies effectively cure many women, rather than simply delaying the recurrence of disease.

12 May 2005

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised

Current guidelines generally recommend the initiation of statin therapy when the estimated 10-year risk of a non-fatal heart attack or coronary death is at least 15-20%.

12 May 2005

Data from its 43 million Medicare patients to be used to track side effects of drugs

The Medicare program in the U.S. plans to use data from its 43 million patients in order to accelerate the detection of dangerous side effects from drugs already on the market.

11 May 2005

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

The often embarrassing, excessive sweating disorder, hyperhidrosis, and its treatment options are gaining greater attention from physicians. This is improving the efficacy of treatment and minimizing its adverse effects, Mayo Clinic authors write in the May issue of Mayo Clinic Proceedings.

11 May 2005

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against some of the most deadly agents of bioterrorism including anthrax, botulinum toxin, Ebola virus, pneumonic plague, smallpox and tularemia.

11 May 2005

MicroVention awarded key patent for Smart Hydrogel

MicroVention announced today that the U.S. Patent and Trademark Office has awarded the company U.S. Patent No. 6,878,384 for its proprietary environmentally-responsive or "smart" hydrogel called Intelligel.

11 May 2005

Targeted Genetics announces new patent for Hyperlipidemia

Targeted Genetics Corporation announced today issuance of U.S. patent #6,887,463, entitled, "Methods and Compositions for Gene Therapy for the Treatment of Defects in Lipoprotein Metabolism."

11 May 2005

Coping with pain quite a struggle for half of the U.S.A.

At least 50 precent of the U.S. population are struggling to cope either with the aggravation of intermittent pain or with the misery of chronic pain which is difficult to treat. This results in less work, crankier moods and fewer activities, combined with a wide-ranging search for pain relief.

11 May 2005

Aspirin aids recovery following heart bypass surgery

Many patients who regularly take aspirin to thin their blood prior to undergoing coronary artery bypass surgery, have in the past been told to stop the aspirin a week before the operation, but new research has found that they may be better off taking it.

11 May 2005

Earlier treatment of perinatal HIV associated with decreased HIV progression

In a study in the May 11 JAMA, earlier treatment of children with HIV infection with ART is associated with less HIV progression and improved survival rates.

10 May 2005

Therapy News and Research

Tamoxifen study counters hopes that drug might protect the heart

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

Drug trio increases survival rate in head and neck cancers

Doctors and patients think differently about clinical trials

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Herceptin could be used safely for bladder cancer

Robotic surgery dramatically reduces physical trauma for head & neck cancer patients

First advance in pancreatic cancer treatment in a decade offers new hope

Great news for breast cancer patients

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised

Data from its 43 million Medicare patients to be used to track side effects of drugs

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

MicroVention awarded key patent for Smart Hydrogel

Targeted Genetics announces new patent for Hyperlipidemia

Coping with pain quite a struggle for half of the U.S.A.

Aspirin aids recovery following heart bypass surgery

Earlier treatment of perinatal HIV associated with decreased HIV progression

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News